ANT-INTERNATIONAL
On 2024 International MSME Day, Ant International, a digital payment and financial services leader, shares that it supports almost 100 million Micro, Small, and Medium-sized Enterprises (MSMEs) worldwide across its businesses and partner programs; and reinforces its commitments towards MSME digitalization and inclusion through the expansion of its services, new programs for skills development with industry partners, and a new global campaign.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626356788/en/
(Photo: Business Wire)
“MSMEs are the lifeblood of our economies, driving innovation, employment, and inclusive development,” said Douglas Feagin, President of Ant International. “Their resilience and entrepreneurial spirit deserve to be celebrated and nurtured. At Ant International, we firmly believe in the power of small and that small businesses can make a big impact. Fintech innovations today unlock new possibilities for small businesses to dream boldly and compete globally. Together with our partners, we want to ensure that every business and every person will have access to the knowledge, network, and digital tools to help them achieve their goals.”
Empowering growth for MSMEs through digitalization
Across its businesses, Ant International offers solutions that enable MSMEs to digitalize, opening new growth opportunities.
Alipay+, the cross-border mobile payments and marketing solutions operated by Ant International, announced an expansion of its global acceptance. As of June 2024, Alipay+ is accepted by over 90 million merchants in over 66 markets, connecting businesses to users of 30 international payment partners. With travel picking up and tourism a key driver of many local economies, this enables many small businesses to connect with global mobile-first consumers in a simple, cost-efficient manner.
A key development in driving digitalization at scale is through Alipay+’s integration with national QRs. Alipay+ is currently integrated with the national QRs of Singapore, Malaysia and South Korea, which counts MSMEs as majority of its merchants. In Singapore, Alipay+ transactions at hawker stalls have increased 52% in H1 2024, compared to H2 2023. In Malaysia and South Korea, Alipay+ transactions increased 44% and 54% respectively via PayNet and ZeroPay, in Q2 vs Q1 2024. Alipay+ also has partnerships with national QRs in Cambodia, Nepal and Sri Lanka.
As a leading provider of digital payment solutions, Antom supports merchants of all sizes, including MSMEs, across over 40 countries and regions. Through a single integration, Antom connects them to more than 250 payment methods in over 150 markets. Its D-store solution enables MSME merchants to digitalize their operations and set up an online store in just 10 minutes with zero upfront cost. Over 5000 outlets have already onboarded this solution, with average monthly transactions growing by 27% in Q2 vs Q1 2024.
In supporting MSMEs to do business globally, WorldFirst empowers more than 1 million SMEs with international payments to 200+ markets in over 100 currencies. To enable more SMEs to do cross-border trade, WorldFirst will expand to more markets in Southeast Asia and Europe this year. ANEXT Bank, a digital wholesale bank incorporated in Singapore, recently celebrated its second anniversary, with two times year-on-year increase in its customer base, of which 69% are micro businesses. To further support regional MSMEs, ANEXT Bank has introduced its second batch of SME Friends of ANEXT with forward-thinking small and growing businesses to co-create the “digital bank of tomorrow”.
Ant International has also recently unveiled bettr, a new global digital lending service to provide micro lending to MSMEs through embedded finance partnerships, further accelerating financial inclusion.
Harnessing industry partnerships to drive MSME development
Ant International believes in open industry collaboration to jointly support knowledge and skills development for MSMEs.
In Indonesia, Ant International and DANA will launch the second edition of SisBerdaya, an initiative that provides female micro entrepreneurs training, mentoring, and educational programs in business management and digital skills. Started in 2023, the first edition drew more than 2700 applicants, with 180 participants undergoing a one-month training, and grants awarded to 30 entrepreneurs.
In collaboration with the International Finance Corporation, 10x1000 Tech for Inclusion is an open learning platform to help future digital leaders develop more skills to drive greater impact within their communities. As of 2023, with the support of 40+ global strategic partners, more than 6,000 individual talents from 100+ countries and regions completed the 10x1000 learning programs, of which 90% are from developing markets and 60% work in MSMEs.
Earlier this year, Ant International launched Programme Sirius, with the support of 13 Asia Pacific fintech leaders to empower MSMEs in their transition towards sustainability, in line with the United Nationals Sustainable Development Goals.
Global campaign to ‘Embrace the power of small’
In celebration of International MSME Day, Ant International launches its “Embrace the power of small” campaign featuring three business owners and their journeys of digitalization. The business owners are:
Cholthicha Joyyangsuk (Numwan), Thailand – a micro entrepreneur in Bangkok selling Thai desserts on her tuktuk. With Alipay+, she can now easily accept mobile payments from tourists, sharing a slice of culture, while giving her access to a wider pool of customers.
Lem Cheong, The Hainan Story, Singapore – inspired by his grandma’s rich heritage and flavourful recipes, Mr Cheong aims to evolves traditional dishes, just as he evolves his business with digital tools like Antom’s D-store solution to simplify his store operations.
Lewis Ames, Wrimes Cosmetics, UK – starting with neon face paint and pivoting to pet care during the pandemic, Mr Ames uses WorldFirst to pay his suppliers and collect payments from marketplaces easily, so he can grow his business from Stevenage to the world.
These stories will be featured on out-of-home billboards, starting in Europe, in time for the UEFA EURO 2024, of which Ant International is the Official Payment Partner, and rolled out to other global markets, and also on TV and social media.
About Ant International
Headquartered in Singapore, Ant International powers the future of global commerce with digital innovation for everyone and every business to thrive. In close collaboration with partners, we support merchants of all sizes worldwide to realize their growth aspirations through a comprehensive range of tech-driven digital payment and financial services solutions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240626356788/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment17.9.2025 14:00:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the launch of a new brand, “Hada no Aozora Clinic”, scheduled to open in Tokyo on October 1, 2025. This clinic will adopt a hybrid dermatology model that integrates insurance-covered general dermatology and private-pay aesthetic treatments, advancing SBC’s multi-brand strategy in the rapidly expanding aesthetic medicine market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917897380/en/ SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment As life expectancy continues to rise and demographic aging accelerates, more people are seeking treatments that help them maintain both well-being and a youthful appearance over a longer lifespan. Within this environment, aesth
Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board17.9.2025 14:00:00 CEST | Press release
IND clearance marks second study accepted for RLS-1496, a first-in-class disease-modifying selective GPX4 modulator targeting pathological senescent cells that drive inflammaging and chronic degenerative diseases and conditions associated with the biological aging process through ferroptosis Results from first RLS-1496 study in patients with psoriasis, atopic dermatitis, and skin aging are expected in Q4 2025; the actinic keratosis Phase 1b/2a study will begin in Q4 2025 Rubedo Clinical Advisory Board expands to include globally renowned dermatologist and immunologist Emma Guttman-Yassky, MD, PhD., Waldman Professor of Dermatology and Immunology and Health System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that the U.S
New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs17.9.2025 14:00:00 CEST | Press release
Universal Surveillance Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost Savings Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George Blike and colleagues at Dartmouth-Hitchcock Medical Center in New Hampshire demonstrated that use of Masimo technologies to continuously monitor general floor patients can yield significant cost savings.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917266545/en/ Continuous Patient Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™ In prior studies, the clinical outcome benefits of continuously monitoring patients using Masimo SET® and Patient SafetyNet™ have been shown to include lower mortality, improved resuscitative outcomes, and fewer rapid response team activations and transfers
Merck to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 202517.9.2025 14:00:00 CEST | Press release
Four-year data show nearly 9 in 10 RMS patients remained free from progression independent of relapse activity (PIRA)Results highlight the potential of MAVENCLAD to reduce neurodegeneration and neuroinflammation beyond established clinical efficacy outcomes in RMSEvidence suggests that MAVENCLAD effectiveness could be driven by peripheral and central effects without requiring continuous immunosuppression Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. New four-year data from two large Phase 4 studies highlight the long-term efficacy, favorable disability outcomes and durable impact of MAVENCLAD® (cladribine tablets) in people living with relapsing multiple sclerosis (RMS). These findings are to be presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), being held September 24-26 in
Kinectrics Significantly Increases Isotope Production Capacity to Meet Growing Global Demand17.9.2025 13:30:00 CEST | Press release
Kinectrics, a division of BWX Technologies Inc. (NYSE: BWXT), announced today the completion of a major expansion to its isotope production capabilities, reinforcing its role as a global supplier of highly enriched stable isotopes and establishing the only North American source for Yb-176, reducing the reliance on foreign material for life-saving cancer treatments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917450864/en/ Travis Besanger, Kinectrics VP of Medical Isotopes, speaking within the new Isotope Separation Production Facility at Kinectrics Headquarters in Toronto, Canada. Kinectrics commissioned four new 2nd generation Electromagnetic Isotope Separator (EMIS) units, which will boost its annual production capacity to over 500 grams of Ytterbium-176 (Yb-176), the precursor for Lutetium-177 (Lu-177), by the end of the year. This scaled output will support over 150,000 patient treatments annually. Lu-177 is a medi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom